Menu
Enrolling by invitation NCT07678749

Closed Sinus Lifting Using Xenograft With or Without Liposomal Apigenin-Loaded Scaffold

No phase Interventional Closed Sinus Lift Apigenin Loaded Scaffold

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: sinus lifting.
Who it may be relevant to
Registry conditions: Closed Sinus Lift, Apigenin Loaded Scaffold. Basic parameters: 18 years — 50 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Clinical and Radiographic Evaluation of Closed Sinus Lifting Using Xenograft With or Without Liposomal Apigenin-Loaded Scaffold : A Randomized Controlled Clinical Study

Overview

aims to evaluate the effectiveness of closed sinus lifting using xenograft with or without a liposomal Apigenin-loaded scaffold in the posterior maxilla.

Interventions

  • Procedure sinus lifting
    closed sinus lifting using xenograft + liposomal Apigenin-loaded scaffold, followed by implant placement.

Primary outcome measures

  • 1. Bone height ( Apical Bone Height Gain ): Measured from first implant thread to sinus floor. [Time frame: 6 months]

Eligibility criteria

Inclusion criteria

  • 1\. Partially edentulous patients with a maxillary posterior edentulous ridge for more than 4 months after extraction.

2\. Both males and females. 3. Adults aged between 18-50 years. 4. Systemically healthy individuals.

5\. Residual alveolar ridge height ranging from 4 to 6 mm (measured by preoperative CBCT) 6. No previous surgical or radiation treatment involving the maxillary sinus.

Exclusion criteria

\-

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Alazhar university , cairo, egypt — Cairo

Identifiers

NCT: NCT07678749 · P-ME-25-11

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗